217 related articles for article (PubMed ID: 34976180)
1. Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker.
Kim S; Yeo MK; Kim JS; Kim JY; Kim KH
J Cancer; 2022; 13(1):162-173. PubMed ID: 34976180
[No Abstract] [Full Text] [Related]
2. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: angiogenic markers of neoadjuvant chemoradiation.
Kim HJ; Bae SB; Jeong D; Kim ES; Kim CN; Park DG; Ahn TS; Cho SW; Shin EJ; Lee MS; Baek MJ
Oncol Rep; 2014 Dec; 32(6):2493-500. PubMed ID: 25241658
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
6. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
7. Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Huang MY; Huang CW; Wang JY
Kaohsiung J Med Sci; 2020 Mar; 36(3):152-159. PubMed ID: 31814296
[TBL] [Abstract][Full Text] [Related]
8. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
9. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
10. Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Wang J; Liu J; Wang J; Wang S; Li F; Li R; Liu P; Li M; Wang C
Cancer Cell Int; 2022 Mar; 22(1):117. PubMed ID: 35292026
[TBL] [Abstract][Full Text] [Related]
11. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
Zhang Y; Sun Y; Xu Z; Chi P; Lu X
Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
[TBL] [Abstract][Full Text] [Related]
12. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
He L; Chang H; Qi Y; Zhang B; Shao Q
Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
14. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
Serna G; Ruiz-Pace F; Hernando J; Alonso L; Fasani R; Landolfi S; Comas R; Jimenez J; Elez E; Bullman S; Tabernero J; Capdevila J; Dienstmann R; Nuciforo P
Ann Oncol; 2020 Oct; 31(10):1366-1375. PubMed ID: 32569727
[TBL] [Abstract][Full Text] [Related]
16. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
17. Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Guan B; Xu M; Zheng R; Guan G; Xu B
BMC Cancer; 2023 Nov; 23(1):1099. PubMed ID: 37953237
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
20. RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway.
Yan X; Chen J; Meng Y; He C; Zou S; Li P; Chen M; Wu J; Ding WQ; Zhou J
Cancer Med; 2019 Jun; 8(6):3094-3104. PubMed ID: 31033216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]